- Home
- ACRV vs WIMI Comparison
ACRV vs WIMI Comparison
Compare ACRV & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- WIMI
- Stock Information
- Founded
- ACRV 2018
- WIMI 2015
- Country
- ACRV United States
- WIMI China
- Employees
- ACRV N/A
- WIMI N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- WIMI Computer Software: Prepackaged Software
- Sector
- ACRV Health Care
- WIMI Technology
- Exchange
- ACRV Nasdaq
- WIMI Nasdaq
- Market Cap
- ACRV 47.8M
- WIMI 51.6M
- IPO Year
- ACRV 2022
- WIMI 2020
- Fundamental
- Price
- ACRV $2.09
- WIMI $3.93
- Analyst Decision
- ACRV Buy
- WIMI
- Analyst Count
- ACRV 6
- WIMI 0
- Target Price
- ACRV $17.75
- WIMI N/A
- AVG Volume (30 Days)
- ACRV 464.1K
- WIMI 376.1K
- Earning Date
- ACRV 11-12-2025
- WIMI 01-01-0001
- Dividend Yield
- ACRV N/A
- WIMI N/A
- EPS Growth
- ACRV N/A
- WIMI N/A
- EPS
- ACRV N/A
- WIMI 1.43
- Revenue
- ACRV N/A
- WIMI $61,329,146.00
- Revenue This Year
- ACRV N/A
- WIMI N/A
- Revenue Next Year
- ACRV $805.34
- WIMI N/A
- P/E Ratio
- ACRV N/A
- WIMI $2.75
- Revenue Growth
- ACRV N/A
- WIMI N/A
- 52 Week Low
- ACRV $1.05
- WIMI $2.24
- 52 Week High
- ACRV $8.74
- WIMI $29.20
- Technical
- Relative Strength Index (RSI)
- ACRV 65.95
- WIMI 42.51
- Support Level
- ACRV $1.92
- WIMI $3.61
- Resistance Level
- ACRV $2.05
- WIMI $4.58
- Average True Range (ATR)
- ACRV 0.15
- WIMI 0.27
- MACD
- ACRV 0.01
- WIMI -0.08
- Stochastic Oscillator
- ACRV 97.70
- WIMI 21.68
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.